How does SELECTMD's PB Ratio compare to its peers?

SELECTMD is good value based on its Price-To-Book Ratio (0.8x) compared to the peer average (1.1x).

How does SELECTMD's PB Ratio compare vs other companies in the South American Capital Markets Industry?

SELECTMD is good value based on its Price-To-Book Ratio (0.8x) compared to the South American Capital Markets industry average (1x).

What is SELECTMD's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate SELECTMD's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of SELECTMD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate SELECTMD's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

SELECTMD Stock Overview

Engages in the operation of listed equity funds that track various indexes established by the Jamaica Stock Exchange. More details

SELECTMD fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	1/6

Rewards

Earnings have grown 5.4% per year over the past 5 years

Risk Analysis

Dividend of 2.17% is not well covered by earnings or free cash flows

Makes less than USD$1m in revenue (JMD-91M)

Does not have a meaningful market cap (JMD2B)

My Notes

Capture your thoughts, links and company narrative

Sagicor Select Funds Limited Competitors

Sterling Investments

JMSE:SIL

JA$1.2b

QWI Investments

JMSE:QWI

JA$1.1b

1834 Investments

JMSE:1834

JA$1.4b

MFS Capital Partners

JMSE:MFS

JA$356.6m

Price History & Performance

Summary of share price highs, lows and changes for Sagicor Select Funds
Historical stock prices
Current Share Price	JA$0.75
52 Week High	JA$0.93
52 Week Low	JA$0.53
Beta	0.45
1 Month Change	4.17%
3 Month Change	5.63%
1 Year Change	27.12%
3 Year Change	0%
5 Year Change	n/a
Change since IPO	0%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	SELECTMD	JM Capital Markets	JM Market
7D	0%	2.7%	3.3%
1Y	27.1%	-6.2%	1.6%

Return vs Industry: SELECTMD exceeded the JM Capital Markets industry which returned -6.2% over the past year.

Return vs Market: SELECTMD exceeded the JM Market which returned 1.6% over the past year.

Price Volatility

Is SELECTMD's price volatile compared to industry and market?
SELECTMD volatility
SELECTMD Average Weekly Movement	8.2%
Capital Markets Industry Average Movement	8.9%
Market Average Movement	7.5%
10% most volatile stocks in JM Market	15.0%
10% least volatile stocks in JM Market	4.8%

Stable Share Price: SELECTMD has not had significant price volatility in the past 3 months compared to the JM market.

Volatility Over Time: SELECTMD's weekly volatility (8%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2019	n/a	n/a	www.sagicor.com/en-jm/personal-solution/investment/sagicor-select-funds-ltd

Sagicor Select Funds Limited engages in the operation of listed equity funds that track various indexes established by the Jamaica Stock Exchange. The company was incorporated in 2019 and is based in Kingston, Jamaica. Sagicor Select Funds Limited operates as a subsidiary of Sagicor Investments Jamaica Limited.

Sagicor Select Funds Limited Fundamentals Summary

How do Sagicor Select Funds's earnings and revenue compare to its market cap?
SELECTMD fundamental statistics
Market cap	JA$2.35b
Earnings (TTM)	-JA$119.11m
Revenue (TTM)	n/a

-25.8x

P/S Ratio

-19.7x

P/E Ratio

Is SELECTMD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SELECTMD income statement (TTM)
Revenue	-JA$90.96m
Cost of Revenue	JA$0
Gross Profit	-JA$90.96m
Other Expenses	JA$28.15m
Earnings	-JA$119.11m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.023
Gross Margin	100.00%
Net Profit Margin	130.94%
Debt/Equity Ratio	0%

How did SELECTMD perform over the long term?

See historical performance and comparison

Dividends

2.2%

Current Dividend Yield

0%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/31 20:35
End of Day Share Price	2024/12/30 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sagicor Select Funds Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution